Reticulocyte Hemoglobin Content (CHr / RET-He) in the Athlete Iron Workup: Why Ferritin Reads the Storage Pool on a Four-to-Six-Week Lag, the Real-Time Bone-Marrow Iron-Supply Signal That Catches Iron-Restricted Erythropoiesis Before the Hemoglobin Drops, the Paired RET-He-With-Ferritin-and-sTfR Interpretive Framework, and the SOAP Structure That Carries the Marker Into the Early-Intervention Decision
A 24-year-old female collegiate distance runner presents at the start of week 6 of a 16-week outdoor-track build with a two-week performance regression — threshold pace slowed by 8 seconds per kilometer, submaximal heart rate elevated by 6 bpm, and a universal "heavy legs" complaint across every workout. The in-season panel from pre-camp returned ferritin 38 ng/mL, hemoglobin 13.1 g/dL, hs-CRP 1.4 mg/L, MCV 88 fL — every marker inside the laboratory reference bracket. The primary-care read returned "iron status within reference, no action required, continue training." The read is defensible against the markers that were drawn. The problem is that the signal the presentation is actually generating sits upstream of every marker on the standard panel: iron-restricted erythropoiesis at the bone-marrow precursor level, four to six weeks before ferritin drops, eight to twelve weeks before the hemoglobin breaks the reference floor. The marker that reads bone-marrow iron supply in real time, rather than the storage pool on a four-month lag or the hemoglobin trajectory on a three-month lag, is the reticulocyte hemoglobin content — CHr on the Sysmex platform, RET-He on the Siemens — the hemoglobinization status of the youngest circulating red cells. This is the RET-He interpretation guide for the sports RD: what the marker measures and why its biology is a two-to-four-day read against ferritin's four-month lag, the 28 pg clinical-threshold anchor from the pediatric and dialysis literature and the slightly higher sports-population operating point, the paired RET-He-with-ferritin-and-sTfR interpretive framework that separates functional-iron-deficiency from storage-pool-deficiency from the compound presentation, the four intake presentations that earn the RET-He addition regardless of a clean standard panel, and the SOAP structure that carries the marker into the early-intervention decision before the performance regression becomes an overt anemia.
A 24-year-old female collegiate distance runner, a 5000-and-10000 m specialist in her senior outdoor-track season, presents to the sports RD at the start of week 6 of a 16-week build toward the conference meet. The intake file carries a pre-camp panel of ferritin 38 ng/mL, serum iron 72 µg/dL, TSAT 22 percent, hemoglobin 13.1 g/dL, hematocrit 39.4 percent, MCV 88 fL, MCH 29 pg, RDW 13.6 percent, hs-CRP 1.4 mg/L — every marker inside the laboratory reference bracket. The team physician's read on the panel returned "iron status within reference, no action required, continue training."
The presenting complaint, four weeks later, is a two-week performance regression. Threshold pace has slowed by 8 seconds per kilometer against the week-2 benchmark. Submaximal heart rate at the 70-percent-vVO2max workout is elevated by 6 bpm against the 90-day baseline. Blood lactate at a repeat threshold test is 0.6 mmol/L above the week-2 reference against the same running pace. The athlete reports "heavy legs on every workout, no bounce on the strides, I can't get the breathing to settle at pace." The strength coach's note on the shared training log reads "effort disproportionate to the prescription for the last ten sessions, no sleep or load explanation on the HRV data, something is off."
The problem that the standard iron panel is missing is that iron deficiency moves through the athlete in a four-stage sequence that the ferritin-plus-hemoglobin read cannot cleanly see until the storage pool has already emptied and the hemoglobin trajectory has already broken. The first stage is storage-pool depletion — ferritin falls. The second stage is iron-restricted erythropoiesis — the bone marrow is producing new red cells against an inadequate iron supply, and the newly released reticulocytes carry a hemoglobin content below the reference bracket. The third stage is the appearance of hypochromic microcytic cells in the mature circulating pool — MCV and MCH drift down, RDW drifts up. The fourth stage is overt anemia — hemoglobin breaks the reference floor.
The lag between the storage-pool-depletion signal and the overt-anemia signal is four to six months. The ferritin can be inside the reference bracket while the stage-two signal — iron-restricted erythropoiesis at the bone-marrow precursor level — is already producing an under-hemoglobinized reticulocyte wave that will become the hypochromic mature pool six to eight weeks later and the overt anemia six to eight weeks after that. The ferritin reads the storage pool on a four-month lag. The hemoglobin reads the finished pool on a three-month lag. The marker that reads the bone-marrow iron supply on a two-to-four-day lag — the hemoglobinization status of the youngest circulating red cells — is the reticulocyte hemoglobin content.
This is the RET-He interpretation guide for the sports RD: what the marker is actually measuring at the reticulocyte membrane and why its biology is a two-to-four-day read against ferritin's four-month lag, the 28-picogram clinical-threshold anchor from the pediatric and dialysis literature and the slightly higher operating point the sports-population literature supports, the paired RET-He-with-ferritin-and-sTfR interpretive framework that separates functional-iron-deficiency from storage-pool-deficiency from the compound presentation, the four intake presentations that earn the RET-He draw regardless of a clean standard panel, and the SOAP structure that carries the marker into the early-intervention decision.
What Reticulocyte Hemoglobin Content Actually Measures
A reticulocyte is a nascent red cell released from the bone marrow into the peripheral circulation approximately 24 to 48 hours before it finishes final maturation into a mature erythrocyte. The hemoglobin content of the reticulocyte — the mass of hemoglobin inside the cell at the moment of release — is a direct product of the iron supply the bone-marrow erythroid precursor was working against during the final 72 hours of maturation. The reticulocyte compartment turns over on a two-to-four-day timescale across the peripheral circulation and the reticulocyte hemoglobin content therefore reads the current bone-marrow iron supply on a two-to-four-day lag, rather than the storage-pool status on a four-month lag that ferritin reads or the mature-pool hemoglobin on a three-month lag that the CBC reads.
The assay is a routine addition to the automated CBC on the two major hematology-analyzer platforms. The Sysmex XN and XE platforms report the marker as CHr (reticulocyte hemoglobin content) and the Siemens Advia platform reports the marker as RET-He (reticulocyte hemoglobin equivalent). The two assays are not identical in optical-measurement method but the clinical thresholds the published literature anchors across them are close enough that the sports RD can use either reading against the same interpretive framework. The reference labs now report the marker on the standard CBC panel at most academic medical centers and the direct-to-consumer labs that offer the "reticulocyte count with hemoglobin content" add-on carry the marker at a per-draw cost in the 15-to-30-dollar range.
The property that makes the marker clinically useful to the sports RD is that it is independent of the four-month storage-pool lag that confounds the ferritin read, independent of the three-month mature-pool lag that confounds the hemoglobin read, and independent of the acute-phase-reactant inflation that confounds the ferritin read in the heavily training population. The reticulocyte hemoglobin content reads the current bone-marrow iron supply on a two-to-four-day timescale and surfaces iron-restricted erythropoiesis four to six weeks before ferritin drops into the deficient bracket and six to eight weeks before the hemoglobin breaks the reference floor.
The 28-Picogram Clinical Threshold and the Sports-Population Operating Point
The pediatric and dialysis literature has anchored the clinical threshold for iron-restricted erythropoiesis at a RET-He / CHr value below 28 pg. Below 28 pg, the probability that the bone marrow is producing an under-hemoglobinized reticulocyte wave against an inadequate iron supply is high, independent of the ferritin read, independent of the hemoglobin trajectory, independent of the TSAT value. The threshold was anchored originally against the pediatric iron-deficiency literature (Brugnara 1999 and subsequent work) and the chronic-kidney-disease population on erythropoiesis-stimulating-agent therapy, where the paired question of ESA responsiveness demanded a real-time read on bone-marrow iron supply that the ferritin plus TSAT panel could not supply.
The sports-population literature has not generated a dedicated large-cohort threshold study, but the published work on the running and endurance populations supports an operating point at or slightly above the 28-pg clinical floor — the pattern across the field work is that athletes in iron-restricted erythropoiesis typically present with RET-He in the 28-to-30-pg bracket well before the ferritin breaks the deficient-bracket threshold and well before the hemoglobin trajectory breaks the reference floor. The sports RD anchors the operating target at the slightly tighter 29-to-30-pg bracket to catch the trajectory earlier against the paired ferritin and sTfR read, rather than waiting for the 28-pg hard-threshold crossing.
RET-He / CHr above 30 pg. The reassuring bracket. The bone-marrow iron supply is adequate for current erythropoiesis demand, and the sports RD closes the real-time-iron-supply read against the paired ferritin and sTfR interpretation. If the ferritin is simultaneously above the sports-population repletion target and the hs-CRP is clean against the chronic-training inflammation signal, the iron axis is cleanly repleted and the workup moves to the next differential.
RET-He / CHr between 28 and 30 pg. The intermediate bracket. The bone-marrow iron supply is on the margin and the sports RD treats this bracket as the early-intervention trigger — not as a reassuring read. The paired ferritin and sTfR read structures the intervention choice. A simultaneously low ferritin (below 50 ng/mL in the female-athlete population, below 40 ng/mL in the male-athlete population) with a RET-He in the 28-to-30 bracket is the compound signal that the storage pool is depleted and the bone-marrow iron supply is already restricted — oral iron intervention opens immediately against a 6-to-8-week redraw cadence.
RET-He / CHr below 28 pg. The frank iron-restricted-erythropoiesis bracket. The bone marrow is producing an under-hemoglobinized reticulocyte wave against an inadequate iron supply, and the sports RD coordinates the oral iron intervention (every-other-day dosing against the hepcidin kinetics, 65-to-100 mg elemental iron per dose, with a 50-to-100-mg vitamin C co-ingestion for the gastric-pH-dependent absorption kinetics) with the training-load-reduction plan during the 4-to-6-week repletion window, documents the RET-He value against the ferritin and sTfR context, and schedules a 6-to-8-week redraw against the full iron-plus-RET-He panel.
RET-He / CHr below 26 pg. The compound severe-restriction bracket. The bone-marrow iron supply is severely restricted, the hemoglobin trajectory is likely already breaking downward against the three-month mature-pool lag, and the sports RD coordinates the iron-intervention workup with a sports-medicine referral for the IV iron question if the oral intervention does not move the markers across a single 6-to-8-week cycle. The training-load reduction during the repletion window is more aggressive — 20-to-30-percent volume reduction against the pre-intervention load, with the strength coach and primary care looped on the plan.
The Paired RET-He-With-Ferritin-and-sTfR Interpretive Framework
RET-He reads the real-time bone-marrow iron supply, ferritin reads the storage pool on a four-month lag, and the soluble transferrin receptor (sTfR) reads the tissue-level iron demand that is immune to the acute-phase-reactant confounding that distorts ferritin in the heavily training athlete. The three markers read independent axes of the iron picture and the paired read structures the intervention differently across the configurations.
Normal RET-He, normal ferritin, normal sTfR. The reassuring configuration. The real-time bone-marrow supply is adequate, the storage pool is intact, and the tissue-level demand is not escalated against the supply. The iron axis is cleanly repleted and the sports RD closes the workup.
Low RET-He, low ferritin, normal sTfR. The classic iron-deficient-erythropoiesis configuration without yet-elevated tissue demand. The bone marrow is producing under-hemoglobinized reticulocytes against a depleted storage pool, but the tissue-level demand has not yet escalated to compensate. The intervention is oral iron against a 6-to-8-week redraw cadence and the sports RD anchors the plan against the storage-pool-repletion target.
Low RET-He, normal ferritin, elevated sTfR. The functional-iron-deficiency configuration — the configuration that the ferritin-plus-hs-CRP standard panel cannot cleanly see in the heavily training endurance athlete. The ferritin is inflated by the chronic-training-load acute-phase-reactant signal and the storage pool is not what the ferritin number is reading; the sTfR is elevated against the escalating tissue-level iron demand that the restricted supply has produced; and the RET-He confirms the real-time bone-marrow supply restriction. The intervention is oral iron plus the paired audit of the chronic-training-load inflammatory signal and the hepcidin-elevation pattern that is suppressing the dietary and supplemental iron absorption at the duodenal enterocyte. The sports RD coordinates the training-load review with the strength coach and the primary care alongside the oral iron intervention.
Low RET-He, low ferritin, elevated sTfR. The compound iron-deficiency configuration. The storage pool is depleted, the tissue demand is escalated, and the real-time bone-marrow supply is restricted. The intervention is oral iron at the higher end of the dose bracket (100 mg elemental iron per dose, every other day against the hepcidin kinetics), the paired training-load-reduction plan during the repletion window, and the IV iron referral pathway queued if the oral intervention does not move the markers across a single 6-to-8-week cycle. The sports RD anchors the follow-up cadence at 6 weeks and 12 weeks post-intervention against the full RET-He-plus-ferritin-plus-sTfR panel and documents the compound presentation in the longitudinal file.
The Four Intake Presentations That Earn the RET-He Draw
Any athlete with an unexplained performance regression across a two-to-four-week window against a within-reference standard iron panel. The regression is the stage-two clinical signal of iron-restricted erythropoiesis before the stage-three or stage-four markers break, and the RET-He read closes the real-time bone-marrow supply question that the ferritin cannot answer against a chronic-training-load inflammatory signal. The sports RD who adds the marker to the next scheduled draw sidesteps the standard-panel false-negative that would otherwise defer the iron intervention by six to eight weeks.
Any female endurance athlete in the mid-season or late-season window with ferritin trending downward against the pre-season baseline, even inside the reference bracket. The within-reference ferritin that is nonetheless 20 to 30 ng/mL below the pre-season baseline is the trajectory signal that the stage-one storage-pool depletion is in progress, and the paired RET-He read confirms whether the stage-two iron-restricted-erythropoiesis signal is active before the stage-three MCV/MCH drift surfaces. The marker is the trajectory-anchoring instrument that converts the "ferritin is still in range but moving" clinical signal into a defensible intervention decision.
Any athlete on an active oral iron repletion protocol at the 4-to-6-week midpoint. The RET-He is the first marker to move upward against a successful oral iron intervention, with the signal appearing in the 2-to-4-week window post-initiation against the ferritin that takes 8 to 12 weeks to move cleanly. The mid-intervention draw at week 4 to 6 catches the trajectory confirmation that the intervention is working and anchors the "continue oral versus escalate to IV" decision point without the 8-to-12-week ferritin lag.
Any athlete returning from an iron-depleting event — a GI bleed, a parasitic infection, a prolonged NSAID course, a surgical procedure with significant blood loss, a competitive-season heavy-sweat-and-foot-strike hemolysis window — regardless of whether the standard panel has been drawn. The RET-He baseline draw at the point of iron-demand escalation anchors the intervention plan against the real-time bone-marrow supply read rather than against the storage-pool lag that will not surface the deficit for four months.
The SOAP Documentation
My structure on the presenting collegiate distance runner vignette reads: "Twenty-four-year-old female competitive collegiate distance runner, 5000-and-10000 m specialist, senior outdoor-track season, week 6 of a 16-week build toward the conference meet. Pre-camp iron panel at week 2 reads ferritin 38 ng/mL, serum iron 72 µg/dL, TSAT 22 percent, hemoglobin 13.1 g/dL, hematocrit 39.4 percent, MCV 88 fL, MCH 29 pg, RDW 13.6 percent, hs-CRP 1.4 mg/L — all within laboratory reference. Presents with two-week performance regression: threshold pace slowed by 8 seconds per kilometer against week-2 benchmark; submaximal heart rate at the 70-percent-vVO2max workout elevated by 6 bpm against 90-day baseline; blood lactate at threshold-pace repeat test elevated by 0.6 mmol/L at matched running pace; athlete reports 'heavy legs on every workout, no bounce on the strides, breathing will not settle at pace' across the last ten sessions. Strength coach's load-management review flags disproportionate effort for the prescription without a sleep or load-management explanation on the HRV data. Dietary pattern documents mixed-omnivorous intake with twice-weekly red-meat servings, three-to-four servings of plant-based iron sources per day, consistent vitamin-C co-ingestion with the plant iron, no documented GI issues, and a menstrual history of normal cycle length and non-heavy bleeding. Current supplementation stack carries a disclosed-dose multivitamin at the general-population dose and no standalone iron. Draws ordered today: reticulocyte hemoglobin content (RET-He on the hospital Siemens Advia platform), sTfR, repeat ferritin, repeat hs-CRP, repeat CBC with reticulocyte percentage. Expected turnaround 3 to 5 business days. Working rationale: the within-reference ferritin at 38 ng/mL in a female endurance athlete in the mid-season window is at the pre-season repletion target floor and the standard-panel trajectory from the pre-camp baseline is a trajectory signal that the storage-pool-depletion stage-one of the four-stage iron-deficiency sequence is in progress; the two-to-four-week performance regression against the within-reference panel is the stage-two clinical signal of iron-restricted erythropoiesis at the bone-marrow precursor level that the ferritin cannot read against the chronic-training inflammatory signal; the paired RET-He draw closes the real-time bone-marrow iron-supply question on a two-to-four-day lag rather than deferring the intervention to the eight-to-twelve-week ferritin lag; the sTfR draw structures the paired functional-vs-storage iron-deficiency read. Plan: panel returning in 3 to 5 days; RET-He to be read against the 28-pg clinical-threshold floor and the 29-to-30-pg sports-population operating target against the paired ferritin and sTfR context. Pre-emptive intervention opens today independent of lab return at every-other-day oral ferrous bisglycinate 25 mg elemental iron per dose on alternate mornings with 100 mg supplemental vitamin C co-ingestion against the hepcidin-kinetics-aware dosing schedule (every-other-day dosing produces higher cumulative fractional absorption than daily dosing in the Stoffel 2017 and subsequent trial literature); dietary intervention opens today — fourfold increase in red-meat intake across the week to four servings, dedicated iron-plus-vitamin-C meal pattern at the post-workout window to pair against the muscle-damage-stimulated hepcidin-suppression window, audit of the calcium and polyphenol co-ingestion pattern that is inhibiting the plant-iron absorption at the duodenal enterocyte; training-load review with the strength coach and head coach — 15-percent volume reduction across the next 2 weeks pending the lab return, with the aerobic-base-work preserved and the lactate-threshold-and-above work reduced; 6-week redraw of the full panel scheduled to confirm the intervention is moving the RET-He and ferritin trajectories; primary care looped on the paired-marker read for the sports-medicine-side IV-iron referral queue if the oral intervention does not move the markers across the single 6-week cycle."
The assessment line names the pattern as "stage-two iron-restricted erythropoiesis at the bone-marrow precursor level in a female endurance athlete with a trajectory-signal ferritin at the pre-season repletion floor" rather than "iron status within reference, continue training." The plan line specifies the RET-He assay as the real-time bone-marrow iron-supply instrument that drives the early-intervention decision. The intervention opens today, pre-empts the four-month ferritin lag, and anchors the follow-up cadence at the RET-He trajectory rather than the ferritin trajectory.
The Follow-Up Cadence
RET-He redraw at 4 to 6 weeks post-intervention. The reticulocyte compartment turns over on a two-to-four-day lag and the marker moves upward against a successful oral iron intervention within the first two-to-four weeks. The 4-to-6-week redraw catches the trajectory confirmation that the oral intervention is working at a defensible numeric read against the pre-intervention baseline.
Full iron panel plus RET-He plus sTfR at 10 to 12 weeks post-intervention. The ferritin has moved cleanly on a 10-to-12-week timescale against a successful intervention and the paired panel reads the complete iron-axis repletion status against the pre-intervention baseline. The sports RD closes the intervention arc at this timepoint if the storage pool, the bone-marrow supply, and the tissue demand are all cleanly repleted.
Longitudinal RET-He at the off-season baseline draw and the pre-camp draw. The off-season draw anchors the clean annual baseline without the confound of the heavy-training inflammatory signal and the pre-camp draw anchors each new build's starting bone-marrow iron supply against the full iron-axis panel. The two annual draws structure the longitudinal file for the female endurance athlete across the career arc.
IV iron referral pathway if the oral intervention does not move the markers across a single 6-to-8-week cycle. The oral iron intervention that does not move the RET-He upward across 6 to 8 weeks is a signal that the oral absorption is not adequate against the current demand, that the hepcidin-elevation pattern is more severe than the every-other-day dosing can overcome, or that the compound iron-deficiency configuration requires an IV iron intervention to repair the deficit on a defensible clinical timescale. The sports RD coordinates the referral with sports medicine or primary care and documents the escalation threshold on the plan.
Where Calsanova Fits
The RET-He workflow depends on the intake carrying the correct standard-iron-panel baseline and the performance-regression and training-load context at the same visit as the lab-order decision, the interpretive framework that reads the RET-He against the 28-pg clinical threshold and the 29-to-30-pg sports-population operating target against the paired ferritin and sTfR context, the SOAP template that pre-populates the stage-two iron-restricted-erythropoiesis differential against the paired-marker read, the pre-emptive-intervention workflow that opens the oral iron plan on day one against the hepcidin-kinetics-aware every-other-day schedule rather than deferring until the lab return, and the 4-to-6-week and 10-to-12-week redraw scheduling that catches the RET-He and ferritin trajectories on time against a defensible numeric cadence. Calsanova's clinical intake carries the longitudinal iron-axis file that tracks the ferritin trajectory across the pre-camp, mid-season, and off-season draws independent of a single within-reference read, the lab-integration module that flags the RET-He value against the sports-population operating target and the paired ferritin and sTfR context with reference-threshold flagging, the SOAP template pre-populated against the paired-marker read and the hepcidin-kinetics-aware every-other-day oral iron intervention, the automated 4-to-6-week and 10-to-12-week redraw scheduling that confirms the intervention is moving the markers, and the IV-iron-referral-pathway tracking that documents the sports-medicine escalation across the athlete's career arc.
Ready to move your sports-nutrition clinical workflow into a purpose-built system? [Try Calsanova free for 30 days](/signup?role=dietitian) — no credit card, HIPAA-ready from day one, and the RET-He workup runs cleanly against the longitudinal iron-axis file, the paired ferritin and sTfR interpretive framework, the SOAP template, and the automated follow-up scheduling that catches the real-time bone-marrow iron-supply signal before the storage pool breaks the reference floor.
Ready to modernize your practice?
Calsanova gives dietitians AI-powered meal planning, food recognition, video consultations, and HIPAA-compliant infrastructure.
Start your free trialGet more like this.
Evidence-based writing on nutrition, performance, and the research behind what actually works. No spam, no daily emails — just the good stuff.
Written by Nelson Marques, MS, RD, LD — a registered dietitian and performance nutrition specialist. Founder of Calsanova. More about Nelson
More from the Classroom
Soluble Transferrin Receptor (sTfR) and the sTfR / Log-Ferritin (Thomas) Index in the Heavily Trained Endurance-Athlete Iron Workup: Why Ferritin-Plus-CRP Is Not Enough When Chronic Training-Load Inflammation Sits Above the Reference, the Tissue-Iron-Demand Signal That the Acute-Phase Panel Cannot Confound, and the SOAP Structure That Carries the Index Into the Coordinated Iron-Deficiency Decision
A 26-year-old male competitive triathlete presents at the end of a 20-week Ironman build with an 8-week performance regression — threshold power 285W to 265W, submax heart rate up 7 bpm, flat HRV, no training-load or sleep explanation. Primary care panel returned ferritin 62 ng/mL and hs-CRP 4.8 mg/L — read by the physician as 'iron status normal, mild chronic inflammation consistent with endurance training, continue current training.' The read misses the question the presentation is actually asking: is the within-reference ferritin a genuine storage-pool signal or a chronic-training-inflammation-inflated signal that is masking iron-deficient erythropoiesis at the bone-marrow precursor level. Ferritin is a positive acute-phase reactant and the endurance athlete carrying a chronic hs-CRP of 3-to-6 mg/L for twenty weeks running has an inflation-inflated ferritin that the paired ferritin-plus-CRP discipline cannot cleanly discount — 'defer the iron workup until the off-season' is not an acceptable answer in the final 8 weeks of a competition build. The marker that sidesteps the acute-phase confounding is the soluble transferrin receptor (sTfR), and the interpretive instrument that pairs it against the storage pool is the Thomas index — sTfR divided by log(ferritin). This is the sTfR and Thomas index interpretation guide for the sports RD: what sTfR actually measures and why its biology is immune to the acute-phase-reactant confounding that distorts ferritin, why the chronic hs-CRP elevation that endurance training produces is precisely the population in which the paired ferritin-plus-CRP panel is insufficient, the Thomas index interpretive framework that separates true iron-deficient erythropoiesis from inflammation-inflated ferritin from compound presentations, the four intake presentations that should trigger the sTfR referral regardless of a within-reference ferritin, and the SOAP structure that carries the index into the iron-deficiency decision before the athlete's performance regression becomes a frank anemic presentation.
October 6, 2026
IGF-1 and IGFBP-3 in the Athlete Clinical Workup: Why the Spot IGF-1 Alone Misses the Hepatic GH-Resistance Signature of Low Energy Availability, the Computed Molar Ratio That Reads the Ternary-Complex Biology, the Four Paired-Draw Patterns That Classify the GH-IGF-1 Axis, and the SOAP Structure That Carries the Finding Into the Energy-Availability, Training-Load, and Sports-Endocrinology-Referral Branches of the Plan
A 20-year-old female NCAA Division I distance swimmer presents at week 14 of a 22-week championship build with a six-week plateau on her 200-meter freestyle splits, a 1.2-kilogram loss of DXA-measured fat-free mass, a luteal-phase deficiency on a four-month basal-body-temperature chart, a 24-hour recall log at 2,100 kcal against an estimated 2,750-kcal need, and a team-physician-ordered IGF-1 that returned 215 ng/mL. The laboratory report flags the value as within the age-decade reference bracket and the ordering physician's chart note reads IGF-1 normal, no further endocrine workup indicated. The spot IGF-1 reads the panel as reassuring. The integrated growth-hormone-IGF-axis signal that is actually driving the plateau is not readable from the IGF-1 alone. The marker that reads the hepatic GH-resistance signature against the dominant binding-protein pool, insulin-like growth factor binding protein 3 (IGFBP-3), and the computed IGF-1/IGFBP-3 molar ratio that reads against the ternary-complex biology are the two reads the sports RD has to add to the next panel. This is the paired IGF-1 plus IGFBP-3 interpretation guide for the sports RD: the GH-receptor-to-JAK2-STAT5 biology that drives the dissociated storage-versus-synthesis signal, the age-decade reference brackets, the four paired-draw patterns that classify the GH-IGF-1 axis, the four athlete-population presentations that earn the ordered paired draw, the paired-panel assembly against the free-T3-and-gonadal-axis RED-S differential, the SOAP structure that carries the finding into the energy-availability, training-load, and sports-endocrinology-referral branches of the plan, and the eight-to-twelve-week follow-on redraw cadence that tracks the recovery trajectory against the pattern-specific intervention.
November 19, 2026
1,25-Dihydroxyvitamin D vs 25-Hydroxyvitamin D in the Athlete Clinical Workup: Why the Active-Form Assay Reads the Calcium-Demand-Driven Up-Regulation the Storage-Form Trajectory Does Not See, the Four Paired-Draw Patterns That Classify the Vitamin D Endocrine Axis, the Four Athlete-Population Presentations That Earn the Ordered Paired Draw, and the SOAP Structure That Carries the Finding Into the Dietary, Bone-Health, and Sports-Endocrinology-Referral Branches of the Plan
A 28-year-old female collegiate cross-country runner at week 11 of a 16-week outdoor track build presents with a four-week plateau on her 5k pace, muscle soreness extending into day three after her hard sessions, a 24-hour recall log at 1,800 kcal against an estimated 2,400 kcal need, a cycle gap at eight weeks, and a 25-hydroxyvitamin D of 42 ng/mL drawn at her annual physical. The storage-form vitamin D reads replete against both the Endocrine Society and Institute of Medicine reference brackets. The clinician reads the panel as vitamin D sufficient. The persistent symptom complex, the cycle disruption, and the low-energy-availability pattern on the log tell the sports RD the vitamin D endocrine axis is not readable from the 25-OH-D alone. The marker that reads the calcium-demand-driven activation of the renal 1-alpha-hydroxylase — 1,25-dihydroxyvitamin D, calcitriol, the active hormonal form — is the one the sports RD pairs with the storage marker on the next draw. This is the paired 25-OH-D plus 1,25-DH-D interpretation guide for the sports RD: the storage-vs-hormone biology that drives the dissociated read, the Endocrine Society and active-form reference brackets, the four paired-draw patterns that classify the vitamin D endocrine axis, the four athlete-population presentations that earn the ordered paired draw, the paired-panel assembly against the calcium-phosphate-PTH-FGF-23 axis, the SOAP structure that carries the finding into the dietary, bone-health, and sports-endocrinology-referral branches of the plan, and the eight-to-twelve-week follow-on redraw cadence that tracks the recovery trajectory against the pattern-specific intervention.
November 17, 2026